News

Sharp, a part of UDG Healthcare and a leading provider of pharmaceutical packaging and clinical services, has appointed Robert O’Beirn as SVP and Managing Director of its global Clinical Services business. Mr O’Beirn joined UDG Healthcare ten years ago as...

LANXESS India has committed over INR 2.1 crores as part of its CSR spends to support the medical infrastructure in the country in its fight against the Coronavirus pandemic. The spike in COVID-19 cases in the second wave has...

Dr. Reddy's Laboratories Ltd. announced that it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company ("Lilly") for the manufacture and commercialization of the drug, baricitinib, in India. The drug baricitinib has received restricted emergency...

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, announced the company has been ranked first among global Clinical Research Organizations (CROs) for Customer Loyalty and in the...

MedPharm Ltd, the world leader in formulation and development services for topical and transdermal products, has announced a £1.5M refurbishment that will increase laboratory space in the UK by 30%. The renovations will incorporate increased investment in automated technologies to...

The Drugs Controller General of India (DGCI) has approved Bharat Biotech's COVID-19 vaccine Covaxin for phase II/III clinical trial on those aged between two to 18 years. The trial will take place in 525 subjects at various sites, including...

Virtual clinical development specialists, Phesi Inc., are calling for clinical trials to be designed using industry modal values (data values that appear most often in historical trials data) to reduce protocol amendments. Phesi analyzed 330,000 clinical trials from the...